Navigation Links
PacifiCare 'Rescission' Settlement Gives Lip Service to Patient Losses But Stacks Legal Deck in Favor of Insurers
Date:6/19/2008

"Reform" Legislation Given Green Light by Insurers

SANTA MONICA, Calif., June 19 /PRNewswire-USNewswire/ -- A settlement announced today by California health regulators acknowledged that patients should be able to recover unpaid medical bills following illegal cancellations of their health coverage. Yet the details of the settlement stack the legal deck in favor of health insurers, said Consumer Watchdog, allowing them in many cases to evade any payment.

Under the settlement, insurers could use closed-door arbitration proceedings, where patients would likely not be able to afford legal representation, to avoid paying the medical bills racked up by patients both before and after the policy rescission.

"Instead of weak regulatory capitulations to insurance companies we need criminal prosecutions of insurance executives whose companies boost profits by putting a patient's health at risk," said Jerry Flanagan, Health Care Policy Director for Consumer Watchdog. "Today's announcement gives lip-service to giving patients the ability to recover unpaid medical bills and other damages caused by illegal policy cancellations like the loss of a home, but foists an unfair burden on patients to prove that that care was necessary."

Consumer Watchdog said that health insurers and health plans are pushing regulators and the state legislature for "reforms" that favor them in legal proceedings.

"Regulators are saying the right words," said Flanagan, "but they're giving insurers the fine-print exceptions that they seek, and making it easier for the companies to evade their clear legal obligations to patients whose coverage was illegally canceled. In fact, under the settlement, as with those previously announced for Kaiser and Health Net, patients must act as their own attorneys in closed door arbitration proceedings where insurers can overwhelm them with a cadre of their lawyers."

Patients would have to interpret and even try to make complex legal arguments, said Consumer Watchdog. The patients would also be fighting the insurer about the necessity of their medical care in front of arbitration judges with financial ties to the health insurers, not before doctors or medical experts.

A bill before the state Legislature, AB 1945 by Assemblyman Hector De La Torre, would also allow private companies to decide if policy cancellations are warranted, even though such companies operate under financial incentives that favor health insurers. Yesterday, all health insurers and health plans removed their opposition to the bill following industry-friendly amendments and the Senate Health Committee approved the measure.

Consumer Watchdog has urged members of the Senate Judiciary Committee to oppose the measure when it is voted on next Tuesday.

http://www.ConsumerWatchdog.org


'/>"/>
SOURCE Consumer Watchdog
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. AHIP Releases Individual Market Guarantee Access Proposal, Announces Support for Third Party Review of Rescission Decisions
2. Blue Cross of California Responds to Recent Media Coverage of Rescission
3. Dana Corporation, Inc. Enters Into Settlement Agreement With Dana Retiree Committee
4. MaxLife Fund Corp. purchases a portfolio of Life Settlement Policies with a face value of $4,000,000
5. Statement of Eli Lilly and Company on Dr. David Egilman Settlement:
6. $52.5 Million Settlement Against Sepracor Inc. Approved
7. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
8. Bristol-Myers Squibb Finalizes Settlement of Previously Disclosed Federal Investigation into Pricing, Sales and Marketing Practices
9. UGA study: Youth exposed to smokeless tobacco ads despite settlement
10. AARP Calls on State Regulators to Reject Proposed Settlement of TXU Buyout
11. AK Steel Reaches VEBA Health Care Settlement With Middletown Works Retirees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... ... April 25, 2017 , ... ... committed to raising awareness for Duchenne muscular dystrophy, and funding for Duchenne ... (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne announced today. , ...
(Date:4/25/2017)... ... April 25, 2017 , ... Lake Park Dental is now accepting ... Invisalign® in Lutz, FL. With the help of this highly-effective, yet convenient system, ... potential complications, more discretion and less pain. , Drs. Sarah Jockin, Nicole Morganti, ...
(Date:4/25/2017)... ... April 25, 2017 , ... Buyers and sellers in the thriving ... and head shops –can’t help but be heartened by the industry’s current surge. But ... aptly described as “skunk smell.” At last they can simply, safely and effectively ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
(Date:4/24/2017)... ... 24, 2017 , ... The Santana Telehealth Project was honored with the 2017 ... American Telemedicine Association’s annual conference, on April 23 in Orlando, FL. , “I am ... the lives of the poor and underserved in other parts of the world,” said ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... Mass. , April 20, 2017  RXi ... developing innovative therapeutics that address significant unmet medical ... data from the Company,s consumer product development program, ... at the Society for Investigative Dermatology (SID) 76 ... to advance and promote the sciences relevant to ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
Breaking Medicine Technology: